In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Muge BuyukaksoyDepartment of Internal Medicine, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0000-0002-4722-5472 Selin Akturk EsenDepartment of Medical Oncology, Doruk Nilüfer Hospital, 16110 Bursa, Türkiye.
Nesrin TurhanDepartment of Pathology, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.
Enes Seyda SahinerDepartment of Internal Medicine, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.
Imdat ErogluDepartment of Medical Oncology, Faculty of Medicine, Gazi University, 06560 Ankara, Türkiye.ORCID 0000-0001-6619-4141 Aysenur SertDepartment of Pathology, Faculty of Medicine, Gazi University, 06560 Ankara, Türkiye.
Ugur OzberkDepartment of Medical Oncology, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0009-0005-9030-022X Denizcan HasturkDepartment of Internal Medicine, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0000-0002-7318-6702 Oznur BalDepartment of Medical Oncology, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0000-0002-6901-2646 Efnan AlginDepartment of Medical Oncology, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0000-0002-8917-9267 Sebnem YucelDepartment of Medical Oncology, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.
Nuriye OzdemirDepartment of Medical Oncology, Faculty of Medicine, Gazi University, 06560 Ankara, Türkiye.
Onur ErtuncDepartment of Pathology, Faculty of Medicine, Gazi University, 06560 Ankara, Türkiye.
Dogan UncuDepartment of Medical Oncology, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.ORCID 0000-0002-0929-3271 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
ALBI scoreintrahepatic cholangiocarcinomaisocitrate dehydrogenase 1 (IDH1) mutationsurvival
Identifiers
PMID42452749
PMCPMC13363601
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390